Unknown

Dataset Information

0

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy.

ABSTRACT:

SUBMITTER: Nakamura N 

PROVIDER: S-EPMC10092564 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy.

Nakamura Naokazu N   Arai Yasuyuki Y   Kitawaki Toshio T   Jo Tomoyasu T   Mizumoto Chisaki C   Kanda Junya J   Nishikori Momoko M   Yamashita Kouhei K   Takaori-Kondo Akifumi A  

British journal of haematology 20221011 1

Similar Datasets

Unknown Early prediction of cytokine release syndrome by measuring phosphate and magnesium levels following chimeric antigen receptor T cell therapy.
| S-EPMC10749729 | biostudies-literature
Unknown Case Report: Chimeric Antigen Receptor T Cells Induced Late Severe Cytokine Release Syndrome.
| S-EPMC9198280 | biostudies-literature
Unknown Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.
| S-EPMC7936577 | biostudies-literature
Unknown Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.
| S-EPMC5452983 | biostudies-literature
Unknown Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?
| S-EPMC8291836 | biostudies-literature
Unknown Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment.
| S-EPMC7940756 | biostudies-literature
Unknown Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
| S-EPMC8525234 | biostudies-literature
Unknown Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
| S-EPMC7893957 | biostudies-literature
Unknown Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.
| S-EPMC5701525 | biostudies-literature
Unknown [Effect of early tocilizumab intervention on patients with cytokine release syndrome following chimeric antigen receptor T cell therapy].
| S-EPMC10834881 | biostudies-literature